About Absco Therapeutics
Absco Therapeutics is a private company based in Allston, Massachusetts, incorporated in 2024 in Delaware. It has reported $7,000,000 raised in two offerings on Form D since May 2024. Its chief executive is Stephen Linderman.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 18, 2025 | Aug 27, 2025 | $5,000,000fully sold | 1 | $5.0M | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| May 10, 2024 | May 28, 2024 | $2,000,000fully sold | 1 | $2.0M | Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, two offerings | $7,000,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Absco Therapeutics's Form D filed Aug 27, 2025.
SL
Stephen Linderman
Chief Executive Officer and director
CT
Carlo Giovanni Traverso
Director
AS
Avik Som
Director